A developmental timer that fires thousands of genes in precise, phase-locked bursts has been mapped in detail for the first ...

A new study revealed that specific drug-resistance patterns in tuberculosis are linked to altered gene transcription and ...

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...

SDC3 pathway that helps tumors resist immunotherapy. Removing the microRNA reshaped the tumor environment and promoted ...

SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...

Immune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has ...

The findings suggest that future therapies targeting the miR-25–SDC3 pathway could help convert immunotherapy-resistant “cold ...

Series A financing co-led by Balyasny Asset Management, venBio, and Janus Henderson InvestorsRugonersen, a potentially best-in-class antisense ...

Immune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transformed cancer treatment. While these therapies can produce long-lasting ...

Alzheimer's disease is a neurodegenerative disease characterized by a progressive decline in mental functions and memory loss. Along with frontotemporal dementia and some other neurodegenerative ...

Background Chronic pancreatitis (CP) is a progressive fibroinflammatory disorder with persistent immune activation and limited therapeutic options. While physical activity (PA) benefits many chronic ...

One‑and‑done gene edit cut LDL up to 62%; Cleveland labs flag a nitric‑oxide Alzheimer clue. Experts caution on supplements.